Sino Biopharmaceutical Limited (SINOBIOPHARM) balance sheet

HKSE · Healthcare · Medical - Pharmaceuticals · 22,838 employees · CEO S. Y. Tse

Price: HK$4.86 +0.83%
Market cap: HK$86.5B
Enterprise value: CN¥75.5B
Last report: Q2 '26 filed 2026-06-30
Next report: 2027-04-01

At the end of Q2 '26 Sino Biopharmaceutical Limited (SINOBIOPHARM) held CN¥14.9B in cash and short-term investments against CN¥17.2B of debt incl. leases. Total assets CN¥83.2B, total liabilities CN¥37B, shareholders' equity CN¥32.6B.

Balance sheet

Balance sheet	Q3 '23	Q4 '23	Q1 '24	Q2 '24	Q3 '24	Q4 '24	Q1 '25	Q2 '25	Q3 '25	Q4 '25	Q1 '26	Q2 '26
Assets
Cash & equivalents	CN¥9.45B	CN¥9.45B	CN¥8.55B	CN¥8.55B	CN¥9.57B	CN¥9.57B	CN¥19.8B	CN¥11.1B	CN¥12.2B	CN¥7.39B	CN¥14.9B	CN¥14.9B
Short-term investments	CN¥1.55B	CN¥1.55B	CN¥4.63B	CN¥4.63B	CN¥5.03B	CN¥5.03B	CN¥0	CN¥8.72B	CN¥415M	CN¥15.2B	CN¥0	CN¥0
Receivables	CN¥4.6B	CN¥4.6B	CN¥7.3B	CN¥7.3B	CN¥4.97B	CN¥5.01B	CN¥8.29B	CN¥8.29B	CN¥6.01B	CN¥6.64B	CN¥10.7B	CN¥10.7B
Inventory	CN¥1.99B	CN¥1.99B	CN¥1.84B	CN¥1.84B	CN¥2.37B	CN¥2.37B	CN¥2.1B	CN¥2.1B	CN¥2.26B	CN¥2.26B	CN¥1.97B	CN¥1.97B
Other current assets	CN¥2.52B	CN¥2.52B	CN¥61M	CN¥61M	CN¥296M	CN¥251M	CN¥159M	CN¥159M	CN¥2.09B	CN¥1.86B	CN¥465M	CN¥465M
Current assets	CN¥23.8B	CN¥23.8B	CN¥25.2B	CN¥25.2B	CN¥24.7B	CN¥24.7B	CN¥33.8B	CN¥33.8B	CN¥34.5B	CN¥34.5B	CN¥44B	CN¥44B
Property, plant & equipment (net)	CN¥9.91B	CN¥9.91B	CN¥9.68B	CN¥9.68B	CN¥10.3B	CN¥10.3B	CN¥10.1B	CN¥10.1B	CN¥10.2B	CN¥10.2B	CN¥10.1B	CN¥10.1B
Long-term investments	CN¥25.2B	CN¥25.2B	CN¥27.4B	CN¥27.4B	CN¥26.3B	CN¥26.3B	CN¥26.9B	CN¥26.9B	CN¥23.5B	CN¥23.7B	CN¥20.2B	CN¥20.2B
Goodwill	CN¥680M	CN¥680M	CN¥701M	CN¥701M	CN¥916M	CN¥916M	CN¥912M	CN¥912M	CN¥3.5B	CN¥3.5B	CN¥4.35B	CN¥4.35B
Intangible assets	CN¥248M	CN¥2.23B	CN¥2.42B	CN¥2.42B	CN¥2.15B	CN¥2.15B	CN¥2.21B	CN¥2.21B	CN¥192M	CN¥3.56B	CN¥3.76B	CN¥3.76B
Deferred tax assets	CN¥0	CN¥567M	CN¥0	CN¥0	CN¥0	CN¥0	CN¥0	CN¥0	CN¥0	CN¥507M	CN¥0	CN¥0
Other non-current assets	CN¥3.78B	CN¥1.23B	CN¥1.27B	CN¥1.27B	CN¥1.04B	CN¥1.04B	CN¥973M	CN¥973M	CN¥4.16B	CN¥45.7M	CN¥835M	CN¥835M
Non-current assets	CN¥39.8B	CN¥39.8B	CN¥41.5B	CN¥41.5B	CN¥40.7B	CN¥40.7B	CN¥41.1B	CN¥41.1B	CN¥41.5B	CN¥41.5B	CN¥39.2B	CN¥39.2B
Total assets	CN¥63.6B	CN¥63.6B	CN¥66.7B	CN¥66.7B	CN¥65.4B	CN¥65.4B	CN¥74.9B	CN¥74.9B	CN¥76B	CN¥76B	CN¥83.2B	CN¥83.2B
Liabilities
Accounts payable	CN¥1.33B	CN¥1.33B	CN¥2.19B	CN¥2.19B	CN¥1.5B	CN¥1.5B	CN¥2.82B	CN¥2.82B	CN¥1.53B	CN¥1.5B	CN¥2.17B	CN¥2.17B
Accrued expenses	CN¥6.72B	CN¥0	CN¥0	CN¥0	CN¥0	CN¥0	CN¥0	CN¥0	CN¥10.3B	CN¥0	CN¥0	CN¥0
Short-term debt	CN¥11.3B	CN¥11.1B	CN¥8.5B	CN¥8.5B	CN¥7.68B	CN¥7.68B	CN¥8.85B	CN¥8.85B	CN¥8.4B	CN¥8.4B	CN¥8.67B	CN¥8.67B
Taxes payable	CN¥0	CN¥516M	CN¥0	CN¥0	CN¥0	CN¥0	CN¥0	CN¥0	CN¥0	CN¥1.08B	CN¥0	CN¥0
Deferred revenue	CN¥0	CN¥10.1B	CN¥10.8M	CN¥0	CN¥0	CN¥0	CN¥0	CN¥0	CN¥0	CN¥0	CN¥0	CN¥0
Other current liabilities	CN¥3.21B	CN¥12.2M	CN¥11.2B	CN¥11.2B	CN¥10.4B	CN¥7.61B	CN¥13.2B	CN¥13.2B	CN¥4.93B	CN¥10.3B	CN¥16.2B	CN¥16.2B
Current liabilities	CN¥22.6B	CN¥22.6B	CN¥21.9B	CN¥21.9B	CN¥19.6B	CN¥19.6B	CN¥24.9B	CN¥24.9B	CN¥25.2B	CN¥25.2B	CN¥27B	CN¥27B
Long-term debt	CN¥1.07B	CN¥1.07B	CN¥1.01B	CN¥1.01B	CN¥2B	CN¥2B	CN¥3B	CN¥3B	CN¥7.58B	CN¥7.58B	CN¥8.43B	CN¥8.43B
Lease obligations (non-current)	CN¥298M	CN¥298M	CN¥155M	CN¥155M	CN¥83.4M	CN¥83.4M	CN¥84M	CN¥84M	CN¥67.3M	CN¥67.3M	CN¥60.8M	CN¥60.8M
Deferred revenue (non-current)	CN¥0	CN¥548M	CN¥0	CN¥0	CN¥0	CN¥0	CN¥0	CN¥0	CN¥0	CN¥622M	CN¥0	CN¥695M
Deferred tax liabilities	CN¥0	CN¥782M	CN¥0	CN¥0	CN¥0	CN¥0	CN¥0	CN¥0	CN¥0	CN¥286M	CN¥0	CN¥553M
Other non-current liabilities	CN¥1.46B	CN¥125M	CN¥1.47B	CN¥1.47B	CN¥997M	CN¥997M	CN¥1.18B	CN¥1.18B	CN¥1.07B	CN¥165M	CN¥1.45B	CN¥201M
Non-current liabilities	CN¥2.83B	CN¥2.83B	CN¥2.63B	CN¥2.63B	CN¥3.08B	CN¥3.08B	CN¥4.27B	CN¥4.27B	CN¥8.72B	CN¥8.72B	CN¥9.94B	CN¥9.94B
Total liabilities	CN¥25.4B	CN¥25.4B	CN¥24.6B	CN¥24.6B	CN¥22.6B	CN¥22.6B	CN¥29.1B	CN¥29.1B	CN¥33.9B	CN¥33.9B	CN¥37B	CN¥37B
Equity
Common stock & paid-in capital	CN¥415M	CN¥415M	CN¥414M	CN¥414M	CN¥414M	CN¥414M	CN¥414M	CN¥414M	CN¥414M	CN¥414M	CN¥412M	CN¥412M
Retained earnings	CN¥29.3B	CN¥23.6B	CN¥31.8B	CN¥31.8B	CN¥25.3B	CN¥25.3B	CN¥28B	CN¥28B	CN¥25B	CN¥25B	CN¥0	CN¥27.6B
Accumulated other comprehensive income	-CN¥9.95B	-CN¥9.95B	-CN¥9.73B	-CN¥9.73B	-CN¥3.18B	-CN¥3.18B	-CN¥4.4B	-CN¥4.4B	-CN¥4.08B	-CN¥4.08B	CN¥35.1B	-CN¥4.55B
Shareholders' equity	CN¥30.5B	CN¥30.5B	CN¥32.8B	CN¥32.8B	CN¥32B	CN¥32B	CN¥33.4B	CN¥33.4B	CN¥30.7B	CN¥30.7B	CN¥32.6B	CN¥32.6B
Debt
Total debt (incl. leases)	CN¥12.7B	CN¥12.6B	CN¥9.68B	CN¥9.68B	CN¥9.78B	CN¥9.78B	CN¥12B	CN¥12B	CN¥16.1B	CN¥16.1B	CN¥17.2B	CN¥17.2B
Net debt (debt - cash)	CN¥3.19B	CN¥3.13B	CN¥1.13B	CN¥1.13B	CN¥214M	CN¥214M	-CN¥7.87B	CN¥852M	CN¥3.89B	CN¥8.68B	CN¥2.29B	CN¥2.29B

Balance sheet	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25
Assets
Cash & equivalents	CN¥3.5B	CN¥3.69B	CN¥6.24B	CN¥10.6B	CN¥10.6B	CN¥9.6B	CN¥8.65B	CN¥9.45B	CN¥9.57B	CN¥12.2B
Short-term investments	CN¥5.07B	CN¥6.21B	CN¥6.79B	CN¥8.47B	CN¥5.81B	CN¥6.19B	CN¥8.27B	CN¥1.55B	CN¥5.03B	CN¥10.8B
Receivables	CN¥2B	CN¥2.05B	CN¥2.92B	CN¥2.71B	CN¥2.91B	CN¥4.29B	CN¥4.64B	CN¥4.6B	CN¥5.01B	CN¥6.64B
Inventory	CN¥895M	CN¥919M	CN¥1.21B	CN¥1.66B	CN¥1.88B	CN¥1.94B	CN¥2.33B	CN¥1.99B	CN¥2.37B	CN¥2.26B
Other current assets	CN¥1.1B	CN¥710M	CN¥978M	CN¥631M	CN¥1.16B	CN¥1.25B	CN¥1.58B	CN¥2.52B	CN¥251M	CN¥1.47B
Current assets	CN¥12.7B	CN¥13.8B	CN¥18.5B	CN¥24.9B	CN¥22.8B	CN¥23.5B	CN¥25.9B	CN¥23.8B	CN¥24.7B	CN¥34.5B
Property, plant & equipment (net)	CN¥3.15B	CN¥4.27B	CN¥7.03B	CN¥6.98B	CN¥7.16B	CN¥8.52B	CN¥9.25B	CN¥9.91B	CN¥10.3B	CN¥10.2B
Long-term investments	-CN¥3.39B	-CN¥3.94B	-CN¥5.28B	-CN¥6.45B	CN¥5.1B	CN¥19B	CN¥17B	CN¥25.2B	CN¥26.3B	CN¥23.7B
Goodwill	CN¥99M	CN¥88.9M	CN¥13.9B	CN¥13.9B	CN¥88.9M	CN¥648M	CN¥663M	CN¥680M	CN¥916M	CN¥3.5B
Intangible assets	CN¥182M	CN¥219M	CN¥8.35B	CN¥8.93B	CN¥2.16B	CN¥1.06B	CN¥1.25B	CN¥248M	CN¥2.15B	CN¥3.56B
Deferred tax assets	CN¥361M	CN¥383M	CN¥471M	CN¥581M	CN¥463M	CN¥335M	CN¥505M	CN¥0	CN¥0	CN¥507M
Other non-current assets	CN¥5.27B	CN¥6.13B	CN¥6.78B	CN¥9.45B	CN¥9.45B	CN¥7.5B	CN¥9.5B	CN¥3.78B	CN¥1.04B	CN¥55.9M
Non-current assets	CN¥5.67B	CN¥7.16B	CN¥31.2B	CN¥33.4B	CN¥24.4B	CN¥37B	CN¥38.1B	CN¥39.8B	CN¥40.7B	CN¥41.6B
Total assets	CN¥18.4B	CN¥20.9B	CN¥49.8B	CN¥58.3B	CN¥47.2B	CN¥60.5B	CN¥64.1B	CN¥63.6B	CN¥65.4B	CN¥76B
Liabilities
Accounts payable	CN¥827M	CN¥929M	CN¥1.83B	CN¥1.81B	CN¥1.95B	CN¥1.79B	CN¥1.88B	CN¥1.33B	CN¥1.5B	CN¥1.5B
Accrued expenses	CN¥2.39B	CN¥2.77B	CN¥3.25B	CN¥3.56B	CN¥4.19B	CN¥5.15B	CN¥6.3B	CN¥6.72B	CN¥0	CN¥0
Short-term debt	CN¥1.37B	CN¥741M	CN¥2.91B	CN¥667M	CN¥1.55B	CN¥6.52B	CN¥9.66B	CN¥11.1B	CN¥7.68B	CN¥8.42B
Taxes payable	CN¥318M	CN¥496M	CN¥415M	CN¥319M	CN¥266M	CN¥344M	CN¥331M	CN¥516M	CN¥0	CN¥0
Deferred revenue	CN¥0	CN¥0	CN¥122M	CN¥0	CN¥0	CN¥0	CN¥0	CN¥0	CN¥0	CN¥0
Other current liabilities	-CN¥54.4M	CN¥1.25B	CN¥1.56B	CN¥2.06B	CN¥3.22B	CN¥1.82B	CN¥2.24B	CN¥3.35B	CN¥7.61B	CN¥14.6B
Current liabilities	CN¥5.65B	CN¥5.69B	CN¥9.67B	CN¥8.12B	CN¥10.9B	CN¥15.3B	CN¥20.2B	CN¥22.6B	CN¥19.6B	CN¥25.2B
Long-term debt	CN¥1.68B	CN¥2.21B	CN¥507M	CN¥7.88B	CN¥12.4B	CN¥5.21B	CN¥3.93B	CN¥1.07B	CN¥2B	CN¥7.59B
Lease obligations (non-current)	CN¥0	CN¥0	CN¥47.8M	CN¥41.3M	CN¥265M	CN¥320M	CN¥324M	CN¥298M	CN¥83.4M	CN¥67.3M
Deferred revenue (non-current)	CN¥201M	CN¥242M	CN¥533M	CN¥481M	CN¥608M	CN¥674M	CN¥749M	CN¥548M	CN¥558M	CN¥0
Deferred tax liabilities	CN¥169M	CN¥184M	CN¥462M	CN¥1.48B	CN¥172M	CN¥882M	CN¥832M	CN¥782M	CN¥238M	CN¥287M
Other non-current liabilities	-CN¥1.13M	CN¥0	CN¥1.01B	CN¥0	CN¥439M	CN¥381M	CN¥131M	CN¥125M	CN¥202M	CN¥165M
Non-current liabilities	CN¥2.05B	CN¥2.64B	CN¥2.56B	CN¥9.89B	CN¥13.8B	CN¥7.47B	CN¥5.97B	CN¥2.83B	CN¥3.08B	CN¥8.11B
Total liabilities	CN¥7.7B	CN¥8.32B	CN¥12.2B	CN¥18B	CN¥24.8B	CN¥22.8B	CN¥26.1B	CN¥25.4B	CN¥22.6B	CN¥33.9B
Equity
Common stock & paid-in capital	CN¥166M	CN¥170M	CN¥279M	CN¥278M	CN¥416M	CN¥415M	CN¥415M	CN¥415M	CN¥414M	CN¥414M
Retained earnings	CN¥5.34B	CN¥8.47B	CN¥16.8B	CN¥12B	CN¥13.6B	CN¥27.2B	CN¥23.1B	CN¥23.6B	CN¥25.3B	CN¥25B
Accumulated other comprehensive income	-CN¥848M	-CN¥587M	-CN¥463M	-CN¥9.83B	CN¥0	-CN¥9.23B	-CN¥10.1B	-CN¥4.26B	CN¥0	CN¥0
Shareholders' equity	CN¥7.96B	CN¥9.21B	CN¥29.2B	CN¥31.1B	CN¥16.7B	CN¥30.3B	CN¥29.7B	CN¥30.5B	CN¥32B	CN¥30.7B
Debt
Total debt (incl. leases)	CN¥3.05B	CN¥2.95B	CN¥3.41B	CN¥8.62B	CN¥14.2B	CN¥12.1B	CN¥14B	CN¥12.6B	CN¥9.78B	CN¥16.1B
Net debt (debt - cash)	-CN¥454M	-CN¥741M	-CN¥2.82B	-CN¥2.02B	CN¥3.59B	CN¥2.52B	CN¥5.33B	CN¥3.13B	CN¥214M	CN¥3.9B

Standardised from the company's filings; outflows and costs keep the sign the provider reports. Hover a period for its end date. Amounts in CNY.

Cash, investments and debt

quarter ends

The other statements

Income statementRevenue, costs, operating income, net income and EPSOpen Cash flowOperating cash flow, capex, free cash flow, buybacks and dividendsOpen

Sources

Statements, segment revenue, metrics and estimates are standardised from the company's filings.

Data as of 2026-11-02 · Amounts in CNY as reported; price and market cap in HKD.